Changeflow GovPing Healthcare USPTO Patent US12582439B2 for Transcarotid Vasc...
Routine Notice Added Final

USPTO Patent US12582439B2 for Transcarotid Vascular Access Sheath

Favicon for changeflow.com ChangeBridge: Patent Grants - Medical Devices (A61M)
Published March 24th, 2026
Detected March 24th, 2026
Email

Summary

The USPTO has granted patent US12582439B2 for a transcarotid vascular access sheath to BOSTON SCIENTIFIC SCIMED, INC. The patent covers methods, devices, and systems designed to limit or prevent emboli release during interventional procedures in the carotid artery.

What changed

The United States Patent and Trademark Office (USPTO) has issued patent US12582439B2, titled 'Transcarotid vascular access sheath,' to BOSTON SCIENTIFIC SCIMED, INC. This patent, granted on March 24, 2026, with a filing date of June 19, 2020, describes novel methods, devices, and systems for establishing and facilitating retrograde blood circulation in the carotid artery bifurcation. The invention aims to mitigate the risk of emboli release into the cerebral vasculature, particularly during interventional procedures such as stenting, angioplasty, and atherectomy performed via transcarotid or transfemoral approaches.

This patent grant signifies the allowance of intellectual property protection for a specific medical device technology. For medical device manufacturers and related entities, this patent may impact the competitive landscape and potential for future product development or licensing in the area of transcarotid vascular access and embolic protection. Compliance officers in the medical device sector should note this patent as it pertains to a specific technological innovation within cardiovascular interventional procedures.

Source document (simplified)

← USPTO Patent Grants

Transcarotid vascular access sheath

Grant US12582439B2 Kind: B2 Mar 24, 2026

Assignee

BOSTON SCIENTIFIC SCIMED, INC.

Inventors

Sumaira MacDonald, Stewart M. Kume

Abstract

Methods, devices, and systems establish and facilitate retrograde or reverse flow blood circulation in the region of the carotid artery bifurcation in order to limit or prevent the release of emboli into the cerebral vasculature such as into the internal carotid artery. The methods are particularly useful for interventional procedures, such as stenting and angioplasty, atherectomy performed through a transcarotid approach or transfemoral into the common carotid artery, either using an open surgical technique or using a percutaneous technique, such as a modified Seldinger technique or a micropuncture technique.

CPC Classifications

A61B 17/3423 A61B 17/12136 A61B 17/122 A61M 25/09 A61M 25/007 A61M 25/008 A61M 25/0067 A61M 2025/0073 A61M 2025/0387 A61M 2025/0081

Filing Date

2020-06-19

Application No.

16906457

Claims

11

View original document →

Named provisions

Abstract Claims

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582439B2

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Innovation Cardiovascular Interventions
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Product Development
Topics
Cardiovascular Devices Interventional Procedures

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.